Analyzing...
Loading company...
MedPlus Health Services Ltd. engages in the operation of pharmacies. The company is headquartered in Hyderabad, Telangana and currently employs 21,000 full-time employees. The company went IPO on 2021-12-23. The firm is primarily engaged in retail trading of medicines and general items, wholesale cash and carry and pathological laboratory testing services, wholesale trading and manufacturing of pharmaceutical products, fast-moving consumer goods and beauty products. The company operates through two segments: Retail and Diagnostics. The Retail segment is engaged in retail trading of medicines and general items. The Diagnostics segment is engaged in the diagnostic services. The firm operates approximately 3,882 stores in 552 cities distributed across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal, and Maharashtra. Its omni-channel platform enables the Company to service its customers through its stores, as well as its online channels. Its subsidiaries include Optival Health Solutions Private Limited, MHS Pharmaceuticals Private Limited, Kalyani Meditimes Private Limited, and others.
No significant concerns identified
Nothing flagged for monitoring
“Operates in Retail — Organized & E-Commerce.”
₹6,892 Cr revenue.
COGS 73.8%, employees 12.8%.
“pharmacy operations grew by 15.”
“My first question, is that, Madhav, could you explain that 10% plus, you know, SSG? We've seen that after some time now, and you also spoke about in your opening comments, Sujit mentioned the 18.”
“consolidated revenue for the quarter stood at 18,061 million.”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 11.1%▲ | 9.3% |
| ROCE | 12.2%▲ | 11.1% |
| Net Margin | 3.1%▲ | 2.8% |
| EBITDA Margin | 9.8%▲ | 7.6% |
| Debt To Equity | 0.00x▼ | 0.12x |
| Rev Growth 3yr | 14.8%▼ | 15.0% |
| EPS Growth 3yr | 63.7%▲ | 15.2% |
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | ₹6,892 Cr +12.3% | ₹6,136 Cr +9.1% | ₹5,625 Cr +23.4% | ₹4,558 Cr +20.6% | ₹3,779 Cr |
| Other Income | ₹71 Cr +46.7% | ₹49 Cr +21.5% | ₹40 Cr -13.2% | ₹46 Cr +46.9% | ₹31 Cr |
| Total Income | ₹6,964 Cr +12.6% | ₹6,185 Cr +9.2% | ₹5,665 Cr +23.1% | ₹4,604 Cr +20.8% | ₹3,811 Cr |
| COGS | ₹5,085 Cr +9.6% | ₹4,641 Cr +5.7% | ₹4,392 Cr +23.4% | ₹3,558 Cr +19.3% | ₹2,982 Cr |
| ₹6,688 Cr +11.4% | ₹6,001 Cr +7.3% | ₹5,591 Cr +22.7% | ₹4,556 Cr +23.4% | ₹3,693 Cr | |
| Profit Before Tax | ₹275 Cr +50.2% | ₹183 Cr +149.6% | ₹73 Cr +55.7% | ₹47 Cr -60.0% | ₹118 Cr |
| ₹56 Cr +68.6% | ₹33 Cr +320.2% | ₹8 Cr ↑ Recovery | (₹3 Cr) ↓ Decline | ₹23 Cr | |
| Net Profit | ₹220 Cr +46.2% | ₹150 Cr +129.1% | ₹66 Cr +30.9% | ₹50 Cr -47.1% | ₹95 Cr |
| Profit (Owners) | ₹220 Cr +46.1% | ₹150 Cr +129.6% | ₹65 Cr +31.6% | ₹50 Cr -48.1% | ₹96 Cr |
| Minority Interest | (₹0.01 Cr) +85.4% | (₹0.09 Cr) ↓ Decline | ₹0.10 Cr -69.6% | ₹0.34 Cr ↑ Recovery | (₹1 Cr) |
| Other Comprehensive Income | ₹2 Cr | ₹0.15 Cr ↑ Recovery | (₹0.06 Cr) ↓ Decline | ₹0.33 Cr -81.7% | ₹2 Cr |
| EPS | ₹18.32 | ₹12.56 | ₹5.48 | ₹4.17 | ₹8.03 |
| Diluted Shares | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Medplus Health Services Limited has informed the Exchange about Transcript
Newspaper Publication for completion of dispatch of Notice of 20th Annual General Meeting
MEDPLUS: Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Business Responsibility and Sustainability Report for the Financial Year 2025-26
Notice of 20th Annual General Meeting of the Company for the Financial Year 2025-26
Outcome of the Board meeting
MedPlus: Request to Ignore Inadvertent Filing of Investor Presentation
Medplus Health Services Limited has informed the Exchange about Link of Recording
Newspaper Publication - Information regarding the 20th Annual General Meeting of the Company to be held on August 17, 2026 through Video Conferencing / Other Audio Visual Means
Submission of Newspaper clippings
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Medplus Health Services Limited has informed the Exchange about Investor Presentation
Medplus Health Services Limited has informed the Exchange about Investor Presentation
No dividend history available for this company.